[1]
M. Krzyżanowska, K. Kozon, J. Olszewski, and A. Patyra, “Efficacy of satralizumab therapy in the treatment of NMOSD”, Prosp. Pharm. Sc., vol. 21, no. 3, pp. 64–68, Sep. 2023.